Orion Biotech Opportunities (ORIA) Short Interest Ratio & Short Volume

Short interest is the volume of Orion Biotech Opportunities shares that have been sold short but have not yet been closed out or covered. As of April 30th, investors have sold 3,100 shares of ORIA short. 0.02% of Orion Biotech Opportunities' shares are currently sold short. Learn More on Orion Biotech Opportunities' current short interest.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.02% of Orion Biotech Opportunities' floating shares are currently sold short.

Orion Biotech Opportunities saw a decrease in short interest in April. As of April 30th, there was short interest totaling 3,100 shares, a decrease of 24.4% from the previous total of 4,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Orion Biotech Opportunities currently has issued a total of 25,750,000 shares. Some of Orion Biotech Opportunities' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Orion Biotech Opportunities currently has a public float of 19,500,000 shares.

0.02% of Orion Biotech Opportunities' shares are currently sold short. Here is how the short interest of companies compare to Orion Biotech Opportunities: Patria Latin American Opportunity Acquisition Corp. (0.01%), Pearl Holdings Acquisition Corp (0.00%), TortoiseEcofin Acquisition Corp. III (0.03%), Spring Valley Acquisition Corp. II (0.12%), Cartesian Growth Co. II (0.01%), CONX Corp. (0.41%), Investcorp Europe Acquisition Corp I (0.10%), Enphys Acquisition Corp. (0.00%), Keen Vision Acquisition Co. (0.03%), Gores Holdings IX, Inc. (0.02%),

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($4.05 billion), Occidental Petroleum Co. ($3.06 billion), Moderna, Inc. ($2.37 billion), Paramount Global ($2.14 billion), T. Rowe Price Group, Inc. ($2.13 billion), Coinbase Global, Inc. ($2.00 billion), Verisk Analytics, Inc. ($1.94 billion), Extra Space Storage Inc. ($1.77 billion), CarMax, Inc. ($1.59 billion), and Old Dominion Freight Line, Inc. ($1.56 billion). View all of the most shorted stocks.

Short selling ORIA is an investing strategy that aims to generate trading profit from Orion Biotech Opportunities as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Orion Biotech Opportunities occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ORIA, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ORIA, twice per month. The most recent reporting period available is April, 30 2023.